Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.

De Rosa A, De Michele G, Guacci A, Carbone R, Lieto M, Peluso S, Picillo M, Barone P, Salemi F, Laiso A, Saccà F, Tessitore A, Pellecchia MT, Bonifati V, Criscuolo C.

J Parkinsons Dis. 2014;4(1):123-8. doi: 10.3233/JPD-130312.

PMID:
24496098
2.

The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.

Criscuolo C, De Rosa A, Guacci A, Simons EJ, Breedveld GJ, Peluso S, Volpe G, Filla A, Oostra BA, Bonifati V, De Michele G.

Mov Disord. 2011 Aug 1;26(9):1733-6. doi: 10.1002/mds.23735. Epub 2011 Apr 29.

PMID:
21538529
3.

Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.

Floris G, Cannas A, Solla P, Murru MR, Tranquilli S, Corongiu D, Rolesu M, Cuccu S, Sardu C, Marrosu F, Marrosu MG.

Parkinsonism Relat Disord. 2009 May;15(4):277-80. doi: 10.1016/j.parkreldis.2008.06.009. Epub 2008 Sep 20.

PMID:
18805725
4.

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E.

Arch Neurol. 2006 Mar;63(3):377-82.

PMID:
16533964
5.

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.

Ferreira JJ, Guedes LC, Rosa MM, Coelho M, van Doeselaar M, Schweiger D, Di Fonzo A, Oostra BA, Sampaio C, Bonifati V.

Mov Disord. 2007 Jun 15;22(8):1194-201.

PMID:
17469194
6.

Genetic analysis of LRRK2 mutations in patients with Parkinson disease.

Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J.

J Neurol Sci. 2006 Dec 21;251(1-2):102-6. Epub 2006 Nov 9.

PMID:
17097110
7.

[Clinical features of LRRK2-associated Parkinson's disease].

Pchelina SN, Ivanova ON, Emel'ianov AK, Iakimovskiĭ AF.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(12):56-62. Russian.

PMID:
22433811
8.

Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy.

De Rosa A, Criscuolo C, Mancini P, De Martino M, Giordano IA, Pappatà S, Filla A, De Michele G.

Parkinsonism Relat Disord. 2009 Mar;15(3):242-4. doi: 10.1016/j.parkreldis.2008.05.011. Epub 2008 Jul 14.

PMID:
18621566
9.

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.

Goldwurm S, Di Fonzo A, Simons EJ, Rohé CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V.

J Med Genet. 2005 Nov;42(11):e65.

10.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N.

Neurology. 2007 Oct 16;69(16):1595-602.

PMID:
17938369
11.

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.

Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.

Eur J Neurol. 2007 Apr;14(4):413-7.

PMID:
17388990
12.

The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease.

Möller JC, Rissling I, Mylius V, Höft C, Eggert KM, Oertel WH.

Eur J Neurol. 2008 Jul;15(7):743-5. doi: 10.1111/j.1468-1331.2008.02154.x. Epub 2008 May 15.

PMID:
18484993
13.

Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.

Huang Y, Halliday GM, Vandebona H, Mellick GD, Mastaglia F, Stevens J, Kwok J, Garlepp M, Silburn PA, Horne MK, Kotschet K, Venn A, Rowe DB, Rubio JP, Sue CM.

Mov Disord. 2007 May 15;22(7):982-9.

PMID:
17427941
14.

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.

Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Laramie JM, DeStefano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH.

BMC Med. 2008 Nov 5;6:32. doi: 10.1186/1741-7015-6-32.

15.

Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.

Gao L, Gómez-Garre P, Díaz-Corrales FJ, Carrillo F, Carballo M, Palomino A, Díaz-Martín J, Mejías R, Vime PJ, López-Barneo J, Mir P.

Eur J Neurol. 2009 Aug;16(8):957-60. doi: 10.1111/j.1468-1331.2009.02620.x. Epub 2009 Mar 31.

PMID:
19473361
16.

Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.

Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators.

Mov Disord. 2006 Dec;21(12):2257-60.

PMID:
17078063
17.

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, Mondragón Rezola E, Bergareche A, Gorostidi A, Gago B, Estanga A, Larrañaga N, Sarasqueta C, López de Munain A, Martí Massó JF.

Mov Disord. 2014 May;29(6):750-5. doi: 10.1002/mds.25778. Epub 2013 Dec 19.

PMID:
24357540
18.

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population.

Cilia R, Siri C, Rusconi D, Allegra R, Ghiglietti A, Sacilotto G, Zini M, Zecchinelli AL, Asselta R, Duga S, Paganoni AM, Pezzoli G, Seia M, Goldwurm S.

Parkinsonism Relat Disord. 2014 Aug;20(8):911-4. doi: 10.1016/j.parkreldis.2014.04.016. Epub 2014 Apr 25.

19.

Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.

Pchelina SN, Yakimovskii AF, Emelyanov AK, Ivanova ON, Schwarzman AL, Singleton AB.

Eur J Neurol. 2008 Jul;15(7):692-6. doi: 10.1111/j.1468-1331.2008.02149.x. Epub 2008 Apr 24.

PMID:
18435766
20.

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2006 Nov 28;67(10):1786-91. Epub 2006 Oct 18.

PMID:
17050822

Supplemental Content

Support Center